# Early Feasibility Study of the SENSE Device

> **NCT03827720** · NA · COMPLETED · sponsor: **Sense Diagnostics, LLC** · enrollment: 20 (actual)

## Conditions studied

- Hemorrhagic Stroke
- Ischemic Stroke

## Interventions

- **DEVICE:** SENSE Device

## Key facts

- **NCT ID:** NCT03827720
- **Lead sponsor:** Sense Diagnostics, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-06-06
- **Primary completion:** 2020-11-19
- **Final completion:** 2021-01-04
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2021-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03827720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03827720, "Early Feasibility Study of the SENSE Device". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03827720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*